skip to main content
Idioma:
Refinado por: autor: Lombardi, Adriana remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A New Mechanism Involving ERK Contributes to Rosiglitazone Inhibition of Tumor Necrosis Factor-α and Interferon-γ Inflammatory Effects in Human Endothelial Cells
A New Mechanism Involving ERK Contributes to Rosiglitazone Inhibition of Tumor Necrosis Factor-α and Interferon-γ Inflammatory Effects in Human Endothelial Cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

A New Mechanism Involving ERK Contributes to Rosiglitazone Inhibition of Tumor Necrosis Factor-α and Interferon-γ Inflammatory Effects in Human Endothelial Cells

Lombardi, Adriana ; Cantini, Giulia ; Piscitelli, Elisabetta ; Gelmini, Stefania ; Francalanci, Michela ; Mello, Tommaso ; Ceni, Elisabetta ; Varano, Gabriele ; Forti, Gianni ; Rotondi, Mario ; Galli, Andrea ; Serio, Mario ; Luconi, Michaela

Arteriosclerosis, thrombosis, and vascular biology, 2008-04, Vol.28 (4), p.718-724 [Periódico revisado por pares]

Philadelphia, PA: American Heart Association, Inc

Texto completo disponível

Citações Citado por
2
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling

Cantini, Giulia ; Lombardi, Adriana ; Piscitelli, Elisabetta ; Poli, Giada ; Ceni, Elisabetta ; Marchiani, Sara ; Ercolino, Tonino ; Galli, Andrea ; Serio, Mario ; Mannelli, Massimo ; Luconi, Michaela Panigrahy, Dipak

PPAR Research, 2008-01, Vol.2008, p.904041-11 [Periódico revisado por pares]

United States: Hindawi Limiteds

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.